DS

Dipak Shriram Mahakale

Active Director Director DIN 10675633
DIN 10675633 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Dipak Shriram Mahakale

Data last updated:

Dipak Shriram Mahakale is a Director at Wanofi Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10675633
Primary Designation Director
Industry Pharma
First Appointment 20 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jun 20242024Active

Board colleagues of Dipak Shriram Mahakale

NameDINCompanyDesignation
Sharda Deepak Mahakale10675634Wanofi Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Wanofi Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Dipak Shriram Mahakale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipak Shriram Mahakale

Dipak Shriram Mahakale currently holds 1 directorship: Wanofi Pharmaceuticals Private Limited (Director, since 20 Jun 2024).

Dipak Shriram Mahakale was first appointed on 20 Jun 2024 as Director at Wanofi Pharmaceuticals Private Limited.

The current boards of Dipak Shriram Mahakale's companies include Sharda Deepak Mahakale (Wanofi Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available